Overview Esperion is a commercial stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. We have developed and are commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease, or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. Through commercial execution, international partnerships and collab...
Q2 FY2026 — expected 2026-08-08
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001628280-26-016522 | EDGAR | 109K words |
| 2025-03-07 | 2024-12-31 | 0001628280-25-011154 | EDGAR | — |
| 2024-02-27 | 2023-12-31 | 0001628280-24-007066 | EDGAR | — |
| 2023-02-21 | 2022-12-31 | 0001628280-23-004167 | EDGAR | — |
| 2022-02-22 | 2021-12-31 | 0001628280-22-003263 | EDGAR | — |
| 2021-02-23 | 2020-12-31 | 0001628280-21-002865 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001104659-20-026203 | EDGAR | — |
| 2019-02-28 | 2018-12-31 | 0001047469-19-000791 | EDGAR | — |
| 2018-02-20 | 2017-12-31 | 0001047469-18-000899 | EDGAR | — |
| 2017-02-22 | 2016-12-31 | 0001047469-17-000831 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001628280-25-050165 | EDGAR | 34K words |
| 2025-08-13 | 2025-06-30 | 0001628280-25-040139 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023498 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001628280-24-046307 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0001628280-24-036762 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001628280-24-020862 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001628280-23-037195 | EDGAR | — |
| 2023-08-01 | 2023-06-30 | 0001628280-23-026358 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001628280-23-016646 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0001628280-22-027479 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001628280-22-020111 | EDGAR | — |
| 2022-05-03 | 2022-03-31 | 0001628280-22-011885 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-13 | 0001104659-26-082926 | EDGAR | — |
| 2026-04-02 | 0001628280-26-023196 | EDGAR | 77K words |
| 2026-03-10 | 0001628280-26-016230 | EDGAR | — |
| 2026-03-03 | 0001628280-26-013552 | EDGAR | — |
| 2026-01-12 | 0001628280-26-001764 | EDGAR | — |
| 2025-11-06 | 0001628280-25-049866 | EDGAR | — |
| 2025-11-04 | 0001628280-25-048557 | EDGAR | — |
| 2025-10-08 | 0001104659-25-097992 | EDGAR | — |
| 2025-10-07 | 0001104659-25-097506 | EDGAR | — |
| 2025-08-05 | 0001628280-25-037601 | EDGAR | — |
261 total filings indexed. 229 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001434868 |
| Ticker | ESPR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.esperion.com |
| Listed | 2013-06-26 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ESPR (~200 tokens, structured JSON with cryptographic provenance)